Latest Headlines

  1. MKS Announces Ophir® Integrating Spheres For Accurate, Repeatable Measurement Of Optical Power In VCELs
    2/13/2019

    MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced at SPIE Photonics West the Ophir® IS6D integrating spheres for measuring the optical power of widely divergent laser diode sources, such as VCSELs. Part of the Ophir Integrating Spheres series of products, the new spheres can accurately measure light that diverges up to ±85 degrees. Each sphere is delivered as a calibrated unit with a photodiode detector.

  2. MKS Announces Ophir® BeamWatch® Integrated, Fully Automated Beam Monitoring System For Industrial Production Environments
    2/13/2019

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, has announced at SPIE Photonics West Ophir® BeamWatch® Integrated, a fully automated, non-contact laser measurement system designed to measure critical beam parameters in industrial production environments. A rugged, compact, self-contained system, BeamWatch Integrated measures parameters of the focused beam in real-time, including focus spot size, beam caustic, and absolute power readings. The system can accommodate different types of welding heads and includes a variety of interfaces, such as PROFINET and Ethernet/IP, for integration into production networks and automated manufacturing lines to facilitate direct transfer of measurement data.

  3. J&J’s Ethicon To Acquire Auris Health For $3.4B
    2/13/2019

    Focused on creating the next frontier of surgery, Johnson & Johnson, recently announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4B in cash. Additional contingent payments of up to $2.35B, in the aggregate, may be payable upon reaching certain predetermined milestones.

  4. Edwards Lifesciences To Acquire CASMED For $100M
    2/13/2019

    Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has entered into a definitive merger agreement to acquire CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a medical technology company dedicated to non-invasive monitoring of tissue oxygenation in the brain.

  5. FDA Clears Zimmer Biomet’s ROSA One Brain Application
    2/12/2019

    Zimmer Biomet has received U.S. Food and Drug Administration (FDA) clearance for the ROSA One Brain Application, a robotic surgical navigation and positioning system for use in neurosurgical procedures.

  6. Philips Launches Ultrasound System For General Imaging, Ob/Gyn
    2/8/2019

    Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the EPIQ Elite ultrasound system, a new premium ultrasound that combines the latest advances in transducer innovation and enhanced performance to improve clinical confidence and the patient experience.

  7. FDA Grants Breakthrough Designation To Cognoa’s Autism Diagnostic And Digital Therapeutic Devices
    2/7/2019

    Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations from the U.S.

  8. FDA Clears Current Health’s Remote Patient Monitoring Solution
    2/6/2019

    Current Health, an artificial intelligence (AI)-powered wearable, recently announced it has received Class II clearance from the U.S. Food and Drug Administration (FDA) for hospital care.

  9. FDA Approves Software Upgrade For Flowonix Pump Systems
    2/6/2019

    Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Flowonix Maestro™ Software for Clinician Programmers used to program Prometra® Pump Systems.

  10. FDA Grants PMA To Teleflex’s MANTA Vascular Closure Device
    2/4/2019

    Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced that it received premarket approval (PMA) from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.